EQ-5D-5L Instrument clinical trials

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

This study looks at how health costs and quality of life differ between starting treatment for certain blood cancers (CLL/SLL) right away or waiting. It helps us understand the best approach for patients.